Strengths
MSN Laboratories boasts a robust infrastructure with 15 API facilities, including specialized oncology production, enhancing its capacity to meet diverse pharmaceutical needs.
The company has a diverse product portfolio, featuring over 470 APIs and 300 finished dosage forms (FDFs), which allows it to cater to a wide range of healthcare providers and pharmaceutical companies.
MSN Laboratories is recognized for its commitment to sustainability, employing eco-sustainable storage solutions that align with global environmental standards.
The company has a strong global presence, with facilities across multiple continents, enabling it to serve international markets effectively.
MSN Laboratories has a proven track record of innovation, with over 50 first-to-file Abbreviated New Drug Applications (ANDAs) and 30 first-to-launch generics, positioning it as a leader in the generics market.
The brand is perceived as a trustworthy partner in the pharmaceutical industry, which enhances customer loyalty and attracts new clients.
The company's focus on affordability, exemplified by its tagline 'World's Most Affordable Favipiravir at 33Rs', appeals to cost-sensitive markets and healthcare providers.
MSN Laboratories' extensive experience in drug development and manufacturing positions it as a reliable supplier for pharmaceutical companies seeking high-quality Active Pharmaceutical Ingredients (APIs).